OnKure Therapeutics 13G Filing
OnKure Therapeutics, Inc. subject of Schedule 13G filing, indicating a significant change in ownership. The filing was made on May 27, 2026.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.